FDA approves drug for tracheal intubation, surgery or ventilation facilitation

To facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation, the Food and Drug Administration yesterday approved the use of succinylcholine chloride injection USP 200 mg/10 mL. FDA warns that the drug’s side effects include anaphylaxis, hyperkalemia and malignant hyperthermia.
Related News Articles
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…